Progressing towards implementation of lung cancer screening in the VHA

VHA 中肺癌筛查的实施取得进展

基本信息

项目摘要

Anticipated Impacts on Veterans Health Care: Veterans served by the VHA suffer both higher prevalence and higher mortality from lung cancer than the general population. The recent National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung cancer mortality and a 7% reduction in all cause mortality with annual chest CT screening among current and former smokers aged 55-74. Accordingly, several new clinical practice guidelines recommend CT screening for middle-aged smokers - a group which would encompass millions of Veterans. CT screening for lung cancer has the exciting potential to reduce lung cancer death, but also the potential for huge costs to the VHA and adverse outcomes for Veterans if not implemented in a thoughtful fashion. The proposed work is of critical importance to our operational partners, the National Program Offices for Oncology and Pulmonology and the National Center for Health Promotion & Disease Prevention, who have been tasked by the Under Secretary for Health with conducting a clinical demonstration project of implementation of lung cancer screening in the VHA. Background: Despite the impressive efficacy of CT screening at reducing lung cancer mortality, CT screening also has downsides. Almost 40% of NLST participants in the CT arm had a pulmonary nodule detected that required further evaluation to rule out cancer - and 95% of those turned out to be false positive findings. Guidelines for pulmonary nodule evaluation are complex, requiring clinicians to choose between CT surveillance, PET scan, transthoracic needle biopsy, bronchoscopic biopsy, and surgical resection; and are not consistently followed either inside the VHA or in the private sector. Meanwhile, patients who require surgical resection have better outcomes if operated on in centers with expertise in thoracic surgery. In light of these factors, guidelines recommend that lung cancer screening be conducted in centers with a "comprehensive process" for both screening as well as downstream evaluation and treatment of potential cancers. Whether VA providers perceive the evidence for screening as robust and which sites have the local context in place to ensure successful implementation of comprehensive lung cancer screening programs is unknown. Objectives: To meet the needs of our operational partners and following the revised PARIHS framework, we propose to assess the evidence, context, and facilitators relevant to implementation of lung cancer screening programs in the VHA. This will inform selection of sites for implementation of lung cancer screening programs, tailoring of needs-based implementation strategies for these sites, and planning and execution of the clinical demonstration project of lung cancer screening that our operational partners are leading. Methods: Aim 1: We will conduct an online survey of all VAMC pulmonologists to assess perceptions of evidence and local context for implementation of lung cancer screening at their site. Aim 2: We will conduct diagnostic formative evaluations 2 VA sites that have already implemented lung cancer screening programs to inform planning and implementation of the clinical demonstration project, and then conduct a 3rd, implementation-focused formative evaluation at one of the 6 clinical demonstration project sites to assess success of implementation.
对退伍军人医疗保健的预期影响:由VHA服务的退伍军人遭受更高的患病率 肺癌的死亡率也比普通人群高。最近的国家肺筛查试验 (NLST)显示肺癌死亡率降低20%,全因死亡率降低7%, 55-74岁吸烟者和既往吸烟者的年度胸部CT筛查。因此,一些新的临床 实践指南建议对中年吸烟者进行CT筛查-这一群体将包括 数百万退伍军人。肺癌的CT筛查具有降低肺癌死亡率的令人兴奋的潜力, 此外,如果不实施,VHA的巨大成本和退伍军人的不良后果的潜力, 体贴的时尚拟议的工作对我们的业务伙伴,即国家人权委员会, 肿瘤学和肺病学项目办公室和国家健康促进与疾病中心 卫生局副局长委派他们进行临床示范, 在VHA实施肺癌筛查项目。 背景:尽管CT筛查在降低肺癌死亡率方面有令人印象深刻的效果, 也有缺点CT组中几乎40%的NLST参与者检测到肺结节, 需要进一步评估以排除癌症-其中95%的结果是假阳性结果。 肺结节评估的指南很复杂,需要临床医生在CT 监测、PET扫描、经胸穿刺活检、支气管镜活检和手术切除;以及 无论是在VHA内部还是在私营部门,都是如此。同时,需要手术的病人 如果在胸外科专业中心进行手术,切除术的效果会更好。鉴于这些 由于这些因素,指南建议肺癌筛查应在具有“全面 这是一个“过程”,用于筛查以及潜在癌症的下游评估和治疗。无论VA 提供者认为筛选的证据是可靠的,哪些站点具有适当的本地环境, 确保成功实施全面的肺癌筛查计划是未知的。 目标:为了满足我们的业务伙伴的需要,并遵循经修订的伙伴关系框架,我们 建议评估与实施肺癌筛查相关的证据、背景和促进者 在VHA的节目。这将为选择实施肺癌筛查计划的研究中心提供信息, 为这些研究中心定制基于需求的实施策略,并规划和执行临床 我们的业务伙伴正在领导的肺癌筛查示范项目。 方法:目标1:我们将对所有VAMC肺病学家进行在线调查,以评估 在其研究中心实施肺癌筛查的证据和当地背景。目标2:我们将 诊断形成性评价2个VA研究中心已经实施了肺癌筛查计划, 通知临床示范项目的规划和实施,然后进行第三次, 在6个临床示范项目地点之一进行以实施为重点的形成性评价,以评估 成功实施。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Renda Soylemez Wiener其他文献

Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension
系统性硬化症相关性肺动脉高压患者左心室纵向应变区域模式的聚类分析
  • DOI:
    10.1016/j.ijcard.2024.132891
  • 发表时间:
    2025-02-15
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Justin K. Lui;Matthew Cozzolino;Morgan Winburn;Marcin A. Trojanowski;Renda Soylemez Wiener;Michael P. LaValley;Andreea M. Bujor;Deepa M. Gopal;Elizabeth S. Klings
  • 通讯作者:
    Elizabeth S. Klings
Longitudinal Assessment of Communication With Patient-Reported Outcomes During Lung Cancer Screening
肺癌筛查期间与患者报告结果的沟通的纵向评估
  • DOI:
    10.1016/j.chest.2024.06.3817
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    8.600
  • 作者:
    Christopher G. Slatore;Sara E. Golden;Liana Schweiger;Ian Ilea;Donald R. Sullivan;Sean P.M. Rice;Renda Soylemez Wiener;Santanu Datta;James M. Davis;Anne C. Melzer
  • 通讯作者:
    Anne C. Melzer
Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot Trial
新诊断的小肺结节患者的情绪困扰、焦虑和总体健康状况:Watch the Spot 试验的结果
  • DOI:
    10.1016/j.chest.2023.06.022
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    8.600
  • 作者:
    Michael K. Gould;Beth Creekmur;Lihong Qi;Sara E. Golden;Celia P. Kaplan;Eric Walter;Richard A. Mularski;Laszlo T. Vaszar;Kathleen Fennig;Julie Steiner;Evan de Bie;Visanee V. Musigdilok;Danielle A. Altman;Debra S. Dyer;Karen Kelly;Diana L. Miglioretti;Renda Soylemez Wiener;Christopher G. Slatore;Rebecca Smith-Bindman
  • 通讯作者:
    Rebecca Smith-Bindman
Gaps in access to pulmonary hypertension care and opportunities for improvement: a multi-site qualitative study
  • DOI:
    10.1186/s12890-025-03817-4
  • 发表时间:
    2025-07-28
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Kari R. Gillmeyer;Sara Shusterman;Seppo T. Rinne;A. Rani Elwy;Renda Soylemez Wiener
  • 通讯作者:
    Renda Soylemez Wiener
Hospitalization as an opportunity to engage underserved individuals in shared decision-making for lung cancer screening: results from two randomized pilot trials
  • DOI:
    10.1007/s10552-022-01620-8
  • 发表时间:
    2022-08-23
  • 期刊:
  • 影响因子:
    2.100
  • 作者:
    Hasmeena Kathuria;Adrian Gunawan;Matthew Spring;Sara Aijaz;Vinson Cobb;Carmel Fitzgerald;Cornelia Wakeman;Jinesa Howard;Mary Clancy;Alexis Gallardo Foreman;Ve Truong;Carolina Wong;Katrina Steiling;Karen E. Lasser;Katia Bulekova;Renda Soylemez Wiener
  • 通讯作者:
    Renda Soylemez Wiener

Renda Soylemez Wiener的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Renda Soylemez Wiener', 18)}}的其他基金

Achieving appropriate, safe, and patient-centered lung cancer screening
实现适当、安全和以患者为中心的肺癌筛查
  • 批准号:
    10296365
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension
与磷酸二酯酶 5 抑制剂不当治疗肺动脉高压相关的因素和结果
  • 批准号:
    10308568
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension
与磷酸二酯酶 5 抑制剂不当治疗肺动脉高压相关的因素和结果
  • 批准号:
    10308380
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension
与磷酸二酯酶 5 抑制剂不当治疗肺动脉高压相关的因素和结果
  • 批准号:
    10016133
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension
与磷酸二酯酶 5 抑制剂不当治疗肺动脉高压相关的因素和结果
  • 批准号:
    9927919
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension
与磷酸二酯酶 5 抑制剂不当治疗肺动脉高压相关的因素和结果
  • 批准号:
    9079779
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Factors and Outcomes Associated with Inappropriate Prescribing of Phosphodiesterase-5-Inhibitors for Pulmonary Hypertension
与磷酸二酯酶 5 抑制剂不当治疗肺动脉高压相关的因素和结果
  • 批准号:
    10296123
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Improving decisions about evaluating pulmonary nodules for lung cancer
改进评估肺癌肺结节的决策
  • 批准号:
    8130773
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Improving decisions about evaluating pulmonary nodules for lung cancer
改进评估肺癌肺结节的决策
  • 批准号:
    8319530
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Improving decisions about evaluating pulmonary nodules for lung cancer
改进评估肺癌肺结节的决策
  • 批准号:
    8005968
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了